The Biosensor Market encompasses several technologies and product categories designed to detect biological substances and convert biological interactions into measurable signals. Market Research Future segments the industry by application, technology, type, end use, and geography. The market is projected to grow at a 9.00% CAGR from 2026 to 2035.

By technology, electrochemical biosensors represent a dominant segment because of their widespread use in glucose monitoring and other clinical applications. Optical biosensors are also gaining attention due to improvements in fluorescence, surface plasmon resonance, and other optical detection techniques. Piezoelectric, thermal, and microwave technologies provide additional opportunities for specialized applications.

By type, wearable, implantable, invasive, and non-invasive biosensors address different monitoring requirements. Wearable and embedded configurations are expected to experience particularly strong growth as consumers and healthcare providers increasingly seek continuous health information.

Healthcare is a major application area, supported by demand for medical diagnostics and chronic disease monitoring. Food safety and environmental monitoring are also important applications, where rapid detection of contaminants and biological substances can improve safety and operational efficiency.

Point-of-care testing represents a major end-use category because biosensors can provide quick results outside traditional laboratory environments. Laboratory testing and research and development also contribute to demand.

Future product development is expected to focus on miniaturization, improved sensitivity, multiplexed detection, connectivity, and artificial intelligence integration. These advances can broaden biosensor applications and support their adoption across both clinical and non-clinical industries.